ALL aboard, writers, readers and erasers! The jouRNAy will be granted and kept BP 3
Cancer cells are relentless in their quest to grow and divide, often rewiring their metabolism and modifying RNA to stay one step ahead. Now,…
Leggi →Archivio
Tag: anticancer drug
From kidney disease to oncology: the power of AI to improve drug discovery and selectivity
Clinical stage generative artificial intelligence (AI)-driven biotechnology company InSilico Medicine (“InSilico”), today announced that the Journal of Medicinal Chemistry, an academic journal focusing on critical…
Leggi →
Rare cancers narrowed by another “inib”: clinical trial warrants hope for neuroendocrine tumors
More than 12,000 people in the United States are diagnosed with a neuroendocrine tumor each year. The tumors begin in neuroendocrine cells – which…
Leggi →Melanoma: the N-Ras mutation is stoppable for the upstream
Melanoma is a type of skin cancer that accounts for 1% of all skin cancer cases. Despite this small percentage, melanoma is responsible for a large number of skin…
Leggi →
Tissue Factor: watching cancer cells dying on TV
A brand new type of cancer drug that acts as a ‘Trojan horse’ to get inside tumor cells has shown promise in patients with…
Leggi →Cancer stem cells: an “old glory” works unexpectedly great against
Cancer stem cells (CSCs), also known as cancer-causing cells, are a hot topic among researchers. These cells are resistant to current treatments and play…
Leggi →Silver bullets for cancers: now it’s time to believe it “on the word”
Apart from the fiction related to werewolves, there has always been talk of finding a “silver bullet” to kill tumors, as declared by the…
Leggi →